Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)

¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)

When proton-coupled carbon-13 spectra are simplified by a broadband proton decoupling technique, structural information about the coupled protons is lost. Distortionless enhancement by polarization transfer (DEPT) is a technique that provides information on the number of hydrogens attached to each carbon in a molecule. While the DEPT experiment utilizes complex pulse sequences, the pulse delay and flip angle are specifically manipulated. The resulting signals have different phases depending on...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The new chemistry of mind: a hypothesis.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2008

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Preparation of DMMTA^V and DMDTA^V Using DMA^V for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

DMT at fifty.

Stephen Szára¹

¹siszara@earthlink.net

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology

|May 31, 2008

Summary

N,N-Dimethyltryptamine (DMT) research faced legal hurdles, hindering early medical study. Despite not being a "schizotoxin," its potential as an endogenous neuromodulator and therapeutic aid warrants further investigation.

Area of Science:

Neuroscience
Psychopharmacology
Medical Chemistry

Background:

N,N-Dimethyltryptamine (DMT) has a complex history in medical research, largely due to its classification as a drug of abuse.
Initial suspicions of DMT acting as a "schizotoxin" have not been substantiated by scientific evidence.
Legal restrictions significantly impeded early research into DMT's effects and potential applications.

Purpose of the Study:

To outline the historical discovery of N,N-Dimethyltryptamine's (DMT) hallucinogenic effects.
To discuss the challenges faced in the medical research of DMT over its first 50 years.
To explore the ongoing potential of DMT in higher brain functions and therapeutic contexts.

Main Methods:

Historical review of research and legal classifications concerning N,N-Dimethyltryptamine (DMT).

More Related Videos

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Published on: May 22, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Preparation of DMMTA^V and DMDTA^V Using DMA^V for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Published on: May 22, 2020

Analysis of early hypotheses regarding DMT's role in psychiatric conditions.

Examination of current perspectives on DMT's endogenous function and therapeutic possibilities.

Main Results:

N,N-Dimethyltryptamine (DMT) was discovered to have hallucinogenic effects.
DMT's research was significantly hampered by legal restrictions and its "drug of abuse" classification.
Evidence does not support DMT as a "schizotoxin".

Conclusions:

While not a "schizotoxin," N,N-Dimethyltryptamine (DMT) may play a role as an endogenous neuromodulator in complex brain functions.
Further clinical research is needed to explore DMT's therapeutic potential, possibly in modified forms or combination therapies.
The therapeutic utility of DMT, particularly as an adjunct to psychotherapy, remains an area for continued investigation.